الصفحة 3
الصفحة 3
Highway
Our idea was generated as a result of the technical and technological shift in almost all industries and its endorsements in reducing costs, increasing efficiency, and serving a wider range of targeted beneficiaries. Three words this business was built on: TRUST, VALUE, and ETHICS. These words are far more endorsed than what the project might explain in terms of business methods, implementations, and processes, but the real aim whether internally or externally is to share the responsibility of improving our industries with creative, competitive ,and relabel business models that could put companies on the wheel of quality improvement and potentially wider the range of the jobs market.
High Availability and Disaster Recovery : Concepts, Design, Implementation
Companies and other organizations depend more than ever on the availability of their Information Technology, and most mission critical business processes are IT-based processes. Business continuity is the ability to do business under any circumstances and is an essential requirement modern companies are facing. High availability and disaster recovery are contributions of the IT to fulfill this requirement. And companies will be confronted with such demands to an even greater extent in the future, since their credit ratings will be lower without such precautions. Both, high availability and disaster recovery, are realized by redundant systems. Redundancy can and should be implemented on different abstraction levels: from the hardware, the operating system and middleware components up to the backup computing center in case of a disaster. This book presents requirements, concepts, and realizations of redundant systems on all abstraction levels, and all given examples refer to UNIX and Linux systems.
Herbal antibiotics : Natural alternatives for treating drug-resistant bacteria ; 2nd ed.
Health care providers have discovered many new resistant strains of bacteria, researchers have added to the growing body of knowledge about herbs, and the need for antivirals to treat emerging infections like SARS and West Nile Encephalitis has become urgent. Within ten years, according to sources cited in the book, pharmaceutical antibiotics will begin to fail at epidemic rates. There are, in fact, no new antibiotics currently in planning or development at any of the major pharmaceutical companies. Most notably, there is none for Gram-negative bacteria, which are emerging as the most dangerous pathogens.
Hazardous Chemicals in Products and Processes : Substitution as an Innovative Process
ubstitution of hazardous substances is a prioritised objective in chemical regulation and risk management. However, it is experienced as a tough task with often inconsistent results. Based on thirteen case studies, this book analyzes substitution as an innovation process and attempts to give answers to the following questions: Why and under which circumstances are companies able and willing to substitute hazardous substances? What are the main drivers and the main barriers? In which way can communication along the supply chain support environmental innovation? How can risk management appropriately deal with the lack of knowledge, with uncertainties and incomplete knowledge about the possible effects of different substances?
Handbook Utility Management
As the deregulation of European utility markets has progressed, the dynamics of and the competitive pressure in the utility industries have steadily intensified over recent years. These changes in the regulatory framework have caused a shift in the direction of an integrated market environment, resulting in new challenges for the management of power and gas companies and a substantial need for strategic reorientation. The Handbook Utility Management is concerned with these changes and challenges in the utility industries and emerging managerial issues of high practical relevance. Inclusion of the latest insights into the economic, technological, and legal drivers of the diverse value chain activities makes the Handbook a valuable asset for both professionals and researchers.
Handbook on Information Technology in Finance
This Handbook contains surveys of state-of-the-art concepts, systems, applications, best practices as well as contemporary research in the intersection between IT and finance. Included are recent trends and challenges, IT systems and architectures in finance, essential developments and case studies on management information systems, service oriented architecture modelling, IT architectures for securities trading, IT-systems in banking, process-oriented systems in corporate treasuries, grid computing and networking. The IT applications in banking, trading and insurance cover risk management and controlling, financial portals, electronic payment and others. In addition, also finance-related IT applications in non-financial companies are considered. The concept-oriented part of the book focuses on IT methods in finance like financial models and modelling financial data, planning and processes, security, algorithms and complexity.
Handbook of Radiopharmaceuticals : Methodology and Applications ; 2nd ed.
A comprehensive review of the field, presenting up-to-date coverage of central topics such as radionuclide production, synthetic methodology, radiopharmaceutical development and regulations, and a wide range of practical applications. A valuable reference work for those new to the Radiopharmaceutical Sciences and experienced professionals alike, this volume explores the latest concepts and issues involving both targeted diagnostic and therapeutic radiopharmaceuticals. Contributions from a team of experts from across sub-disciplines provide readers with an immersive examination of radiochemistry, nuclear medicine, molecular imaging, and more. Features extensive new and revised content throughout Covers key areas of application for diagnosis and therapy in oncology, neurology, and cardiology Emphasizes the multidisciplinary nature of Radiopharmaceutical Sciences Discusses how drug companies are using modern radiopharmaceutical imaging techniques to support drug discovery Examines current and emerging applications of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT)
Handbook of pharmaceutical manufacturing formulations ; Vol.6 : Sterile products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vol.5 : Over-the-counter products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vol.4 : Semisolid products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vol.3 : Liquid products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this six-volume set compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of pharmaceutical manufacturing formulations ; Vo.1 : Compressed solid products
An authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this first volume of a six-volume set, compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent
Handbook of Marketing Decision Models
The HANDBOOK OF MARKETING DECISION MODELS presents the state of the art in marketing decision models, dealing with new modeling areas such as customer relationship management, customer value and online marketing, but also describes recent developments in other areas. In the category of marketing mix models, the latest models for advertising, sales promotions, sales management, and competition are dealt with. New developments are presented in consumer decision models, models for return on marketing, marketing management support systems, and in special techniques such as time series and neural nets. Not only are the most recent models discussed, but the book also pays attention to the implementation of marketing models in companies and to applications in specific industries.
Guanxi and Business Strategy : Theory and Implications for Multinational Companies in China
Guanxi and Business Strategy" elaborates upon a topic of paramount importance to both academic scholars and managers doing business with China: the impact of personal relationships (guanxi) on business affairs. In the Chinese cultural and socio-economic environment, how are the ubiquitous practices of guanxi to be considered in entrepreneurial strategies,Rather than explaining the emergence of guanxi and its persistence – in spite of the existence of a market economy – with Confucianism, the author applies the phenomenon to the methodology of New Economic Sociology. By integrating guanxi into a business context, he shows that the commercial utilization of guanxi with suppliers, customers, competitors and authorities yields significant sustainable competitive advantages.
Growing Modular : Mass Customization of Complex Products, Services and Software
The Time for Mass Customization Has Arrived Opportunity is missed by most people because it is dressed in overalls and looks like work.In the work of mass customization are significant rewards to customer responsiveness, service, and financial performance of any organization. Aiming at the goal of driving lean manufacturing, companies are finding that the strategies that looked like the hardest work, dressed in overalls as Edison would say, are delivering the biggest impact on the financial statements of the companies that boldly take on serving customers in entirely new ways. Driving costs of organizations through more accuracy in orders, assuring that highly configured products are actually what a customer has ordered, and making the many product attributes in complex products accessible for the creation of entirely new production workflows and products, is real and is delivering costs savings while driving up margins.
Grid economics and business models ; 4th International workshop, GECON 2007, Rennes, France, August 28, 2007, Proceedings
In the third contribution, Altmann and colleagues formulate a taxonomical - proach to Grid business models. They survey the development and origin of Grid technologies and focus on the importance of business-directed values when trying to commercialize today’s Grids. Therein, they identify the reduction of costs, the - provement of efficiency, the creation of novel products and services as well as the quality and collaboration between companies as key factors for the differentiation of Grid business models.
Greening the Supply Chain
Since the Rio summit in 1992, the paradigm of corporate environmental responsibility has gradually and consistently extended beyond complying with increasingly stringent environmental regulation and taking up the proactive initiatives of a few world-class companies. Research indicates that the business and financial performance of companies may depend directly on socially and environmentally responsible business practices. Many world-class companies now realize that customers and other stakeholders do not distinguish between a company and its suppliers. As a result, greening the supply chain is an innovative idea which is fast gaining attention in the industry.
Global Product : Strategy, Product Lifecycle Management and the Billion Customer Question
In the early years of the 21st Century, as a result of many changes, it has become possible for the first time for tens of thousands of companies to offer manufactured products to customers across six continents. For many of these "global products", there are potentially more than a billion customers. In 2007, Wall Street hit new highs as the enormous opportunity for increased sales and profits became clear. However the new environment is not easy to manage and the risks are high. Meeting the various requirements of customers from a range of countries, choosing the most suitable locations for the different stages of development and manufacturing, deciding what can be global and what must be local, implementing suitable processes and systems, accommodating different national regulations, and efficiently dividing the workload between diverse sites are among the many challenges faced by providers of global products.
Global investing : A practical guide to the world's best financial opportunities
Relevant information about key stock markets around the world Insights into the underlying dynamics of the world’s major global industries Fulsome discussions on how to evaluate companies within each global industry Advice on how to construct a portfolio of global stocks that will help you to build wealth and protect it during times of stock market weakness Descriptions of free and paid tools that belong on the radar of every successful global investor
Global design to gain a competitive edge : An holistic and collaborative design approach based on computational tools
Global Design to Gain a Competitive Edge collects together papers from the 2008 International Conference on Advanced Design and Manufacture (ICADAM). Recent advancements, emerging trends and new challenges in the fields of design and manufacturing are covered, with a particular focus on the understanding of the impact of distributed team-based design and manufacture on research and industrial practices for global companies.
